← DocG Medical Summaries
Top Pulmonology/Respirology Research Papers
1.
8.5
Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C-Mutated NSCLC.
Overall: A strong randomized phase 3 trial shows that once-daily divarasib meaningfully improves survival and tumor control while reducing severe treatment-related toxicity compared with established KRAS G12C inhibitors.
2.
8.3
Safety of Age-Adjusted and Clinical Probability-Adjusted D-dimer Cut-offs in Suspected Pulmonary Embolism: A Systematic Review and Meta-Analysis.
Overall: A large synthesis of prospective management studies supports adaptive D-dimer thresholds as a practical way to reduce chest imaging while maintaining very low rates of missed clinically important thromboembolism.
3.
8.2
Macrolides for asthma: A systematic review and meta-analysis of randomized trials.
Overall: A rigorous meta-analysis of randomized trials shows a clinically meaningful reduction in severe exacerbations and improved asthma control without increased serious harm, providing strong and actionable evidence despite modest quality-of-life gains and limited regimen details.
4.
7.9
Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity.
Overall: A strong phase 3 trial shows exceptionally large weight loss with meaningful improvements in knee pain and sleep-apnea severity, but incomplete safety reporting and real-world access burdens temper its immediate impact.
5.
7.9
Tozorakimab to Prevent COPD Exacerbations.
Overall: Two large replicate randomized trials found a substantial and consistent reduction in clinically important COPD exacerbations without an apparent adverse-event penalty, although monthly biologic administration may limit routine uptake.
6.
7.8
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy.
Overall: A strong randomized phase 3 trial reports a large and precise survival benefit with fewer severe adverse events, supporting meaningful practice change despite open-label conduct and unresolved access and implementation details.
7.
7.8
Efficacy and safety of gabapentin for treatment of cough in idiopathic pulmonary fibrosis: a randomized, double-blinded, placebo-controlled clinical trial.
Overall: This small but rigorous randomized trial found a large, patient-important improvement in IPF-related cough with an accessible treatment, offset by increased adverse effects and a need for broader confirmation.
8.
7.7
Osimertinib-Savolitinib in Advanced NSCLC after Progression during EGFR-TKI Therapy.
Overall: Osimertinib plus savolitinib produced clinically substantial progression-free and overall-survival gains in a rigorous phase 3 trial, with manageable but frequent toxicity and biomarker-testing requirements.
9.
7.5
Catheter-Directed Thrombolysis in Intermediate-High-Risk Pulmonary Embolism.
Overall: This multicenter randomized trial found a clinically substantial reduction in short-term death, recurrent embolism, or decompensation without higher aggregate bleeding, but open-label assessment, few events, two intracranial hemorrhages, and the need for specialized catheter-based care temper the result.
10.
7.5
Efficacy of Antiinflammatory Therapies for Adults With Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and Network Meta-Analysis.
Overall: A strong synthesis of randomized evidence demonstrates clinically meaningful exacerbation reductions with limited reported harms, but direct impact on routine US primary care is moderated by the specialist-oriented population and treatment context.
Score Guide:
9-10 Exceptional
7-8 Strong
5-6 Moderate
3-4 Weak
1-2 Poor
Top papers in other specialties
Emergency MedicineFamily Medicine / General Practice / Primary CareInternal MedicineAllergy & ImmunologyCardiologyDermatologyEndocrinologyGastroenterologyGeneticsGeriatricsHematologyInfectious DiseaseCritical CareNephrologyNeurologyObesityOccupational & Environmental HealthOncologyPain MedicinePalliative & Supportive CarePhysical Medicine & RehabilitationPsychiatryPublic HealthRheumatologyObstetrics & GynecologyPediatricsAnesthesiologyOphthalmologyOtolaryngology (ENT)OrthopedicsUrologySurgery (Other)Sports MedicineAddiction Medicine